Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Thimme

Showing results (71-80 of 79) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 79 results.
Journal of Internal Medicine|July 2, 2020
Treatment with proton pump inhibitors increases the risk of secondary infections and ARDS in hospitalized patients with COVID-19: coincidence or underestimated risk factor?H Luxenburger, L Sturm, P Biever, et al.
Microbiology Spectrum|October 13, 2025
Frequent high-level rifaximin resistance in <i>Escherichia coli</i> associated with long-term treatment of patients with liver cirrhosis: a prospective, controlled studyL Boll, W V Kern, S Schuster, et al.
Hepatology (Baltimore, Md.)|December 22, 2000
Differential CD4(+) and CD8(+) T-cell responsiveness in hepatitis C virus infectionK M Chang, R Thimme, J J Melpolder, et al.
Alimentary Pharmacology & Therapeutics|January 25, 2017
The albumin-bilirubin grade improves hepatic reserve estimation post-sorafenib failure: implications for drug developmentD J Pinato, C Yen, D Bettinger, et al.
Nature Communications|June 27, 2022
High-dimensional profiling reveals Tc17 cell enrichment in active Crohn's disease and identifies a potentially targetable signatureA-M Globig, A V Hipp, P Otto-Mora, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|June 8, 2014
Transfusion-transmitted hepatitis E in Germany, 2013D Huzly, M Umhau, D Bettinger, et al.
Alimentary Pharmacology & Therapeutics|March 3, 2017
On-target sorafenib toxicity predicts improved survival in hepatocellular carcinoma: a multi-centre, prospective studyJ Howell, D J Pinato, R Ramaswami, et al.
ESMO Gastrointestinal Oncology|April 6, 2026
Spatial immune profiling complements genomic sequencing in biliary tract cancer: hypothesis-generating use casesM Barsch, I Godbole, P Metzger, et al.
Nature Medicine|June 6, 2023
The German Network for Personalized Medicine to enhance patient care and translational researchA L Illert, A Stenzinger, M Bitzer, et al.
Pageof 8

Showing results (71-80 of 79) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 79 results.
Journal of Internal Medicine|July 2, 2020
Treatment with proton pump inhibitors increases the risk of secondary infections and ARDS in hospitalized patients with COVID-19: coincidence or underestimated risk factor?H Luxenburger, L Sturm, P Biever, et al.
Microbiology Spectrum|October 13, 2025
Frequent high-level rifaximin resistance in <i>Escherichia coli</i> associated with long-term treatment of patients with liver cirrhosis: a prospective, controlled studyL Boll, W V Kern, S Schuster, et al.
Hepatology (Baltimore, Md.)|December 22, 2000
Differential CD4(+) and CD8(+) T-cell responsiveness in hepatitis C virus infectionK M Chang, R Thimme, J J Melpolder, et al.
Alimentary Pharmacology & Therapeutics|January 25, 2017
The albumin-bilirubin grade improves hepatic reserve estimation post-sorafenib failure: implications for drug developmentD J Pinato, C Yen, D Bettinger, et al.
Nature Communications|June 27, 2022
High-dimensional profiling reveals Tc17 cell enrichment in active Crohn's disease and identifies a potentially targetable signatureA-M Globig, A V Hipp, P Otto-Mora, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|June 8, 2014
Transfusion-transmitted hepatitis E in Germany, 2013D Huzly, M Umhau, D Bettinger, et al.
Alimentary Pharmacology & Therapeutics|March 3, 2017
On-target sorafenib toxicity predicts improved survival in hepatocellular carcinoma: a multi-centre, prospective studyJ Howell, D J Pinato, R Ramaswami, et al.
ESMO Gastrointestinal Oncology|April 6, 2026
Spatial immune profiling complements genomic sequencing in biliary tract cancer: hypothesis-generating use casesM Barsch, I Godbole, P Metzger, et al.
Nature Medicine|June 6, 2023
The German Network for Personalized Medicine to enhance patient care and translational researchA L Illert, A Stenzinger, M Bitzer, et al.
Pageof 8